EN Uniquely dedicated At Novozymes, we are unique in our dedication to enzymes and microbes. For more than 70 years, our work with these biological problem solvers has made a big difference to our shared world. Novozymes in a nutshell Fast facts Novozymes works with innovative customers across the globe, helping them produce more from less, make their products stand out and reduce costs. Development driver Unrivaled research Global and regional Implementation taskforce Top global employer Explore our 2017 Report Learn about our results, business model, targets, outlook and so much more Go to Annual Report Our purpose explained Our purpose is deeply rooted in our heritage. It also looks ahead to what we can achieve together with customers, consumers, governments, academia and others around us in terms of finding the sustainable answers that our world needs, as our CEO explains. Our approach to sustainability is reflected in our purpose, strategy and long-term targets. The triple bottom line For us, sustainability means adding economic, environmental and social value. Read more Our strategy Partnering for Impact We call our strategy, "Partnering for Impact" and at its core is our belief that we make the biggest impact through partnerships. Our strategy sets out four focus areas. Rally for change We will form partnerships and networks with customers, consumers, governments, suppliers, academia and others around us to make a sustainable difference. Lead innovation We will inspire and excite our customers by delivering more significant innovation, tailored to their local markets. Focus on opportunities We will prioritize the customers, markets and activities that hold the biggest opportunities for creating impact. Grow people We want to be better at enabling our employees to develop their professional and leadership skills. Inspired by the UN's Sustainable Development Goals Our long-term targets We measure the success of our purpose and strategic focus areas using a number of financial and non-financial long-term targets. These ambitious targets reflect the belief that the use of our biological solutions will have a real and positive impact on the world. Reach Educate Catalyze Deliver Save Enable Measuring our success Long-term financial targets Our long-term targets tell us if we are succeeding in helping the world become more sustainable, at the same time as ensuring Novozymes’ continued growth. Return to historical growth rates We expect to return to historical organic growth rates once we successfully commercialize the programs in our innovation pipeline. EBIT Margin We expect to maintain an annual EBIT margin of ≥ 26% from 2016 through to the end of the decade. ROIC We expect to maintain an annual ROIC of ≥ 25% from 2016 through to the end of the decade. Ownership and management Novozymes’ stock consists of two types: A and B shares. Both shares have a nominal value of DKK 2 per share, but an A share carries 10 times as many votes as a B share. Management in Novozymes A/S, the parent company, is headed by Novozymes' Board of Directors and the Executive Leadership Team Read more History Our story in brief 2000 While our roots stretch back to the foundation of Novo Terapeutisk Laboratorium in 1925, our story really began in 2000 when Novo was split into three independent companies: Novo A/S, Novo Nordisk A/S, and Novozymes A/S. We already had a strong portfolio of enzymes at this point, especially for the Food & Beverages and Household Care industries. 2001 – 2011 A number of acquisitions strengthened our business in the bioagriculture sector. In the same decade, we inaugurated the world’s largest enzyme fermentation facility in China. 2011 - 2013 Following the opening of the world’s first commercial-scale cellulosic ethanol plant in Crescentino, Italy, using Novozymes enzymes, the commercial production of cellulosic ethanol continued to broaden globally. In 2012 we inaugurated a plant of our own to produce biofuel enzymes in Nebraska. We now provide enzymatic solutions to the biofuel industry in South and North America and Europe. 2014 - today The BioAg Alliance - formed with Monsanto in 2013 to develop more sustainable solutions for farmers - became fully operational. We also began to work with Adisseo and Boehringer Ingelheim Animal Health on probiotics as a sustainable potential alternative to antibiotic growth promoters in animal feed. In 2017, the application of our products helped reduce CO2 emissions by an estimated 76 million tons, and the Dow Jones Sustainability Index ranked us among the top 6% of companies in the chemical industry sector. Positions & Policies Position papers cover Novozymes’ view on issues that our stakeholders find particularly important. Policies describe how we will conduct our daily work in support of Novozymes' purpose and values. Read more Our shared world. Your impact. From local communities to global challenges, we can make a sustainable difference together. With unrivaled innovation, we advance your business and help you reach your goals. Explore Novozymes Article Novozymes and Boehringer Ingelheim collaborate on probiotics for poultry Article The BioAg Alliance advances new microbial solutions for agriculture Article Novozymes expands in India Article New enzyme blends save costs and enable better detergents Smiley Report Danish Food Authorities' Smiley report for Novozymes Article Novozymes breaks ground for new innovation campus in Denmark Rethink Tomorrow Contact us © 2017 Novozymes Legal Privacy Sitemap